Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Traversa Sergio | CEO | P Purchase | — | $4.14 | $828K | filing |
| Sep 11, 2026 | Shenouda Maged | CFO | P Purchase | — | $4.22 | $844K | filing |
RELMADA THERAPEUTICS (RLMD) insider trades
RELMADA THERAPEUTICS (RLMD) insider trading activity (SEC Form 4). Over the trailing 90 days, RLMD insiders filed 2 purchases totalling $1.7M and 0 sales totalling $0 — net BUYING of $1.7M. Most recent filing: Sep 11, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
2
$1.7M
Sells (90d)
0
$0
Net (90d)
+$1.7M
net buying
Most recent
Sep 11, 2026